NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ark Biotech

Ark Biotech

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://ark-biotech.com

Last Round

Grant

Aug 14, 2025

Total Funding Raised

$16.88M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Ark Biotech is a biotechnology company that develops high-fidelity bioprocess simulation software to optimize cell culture processes and scale production.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Vertical SaaS, Drug Discovery

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

bioprocess simulationvirtual bioreactorin silico experimentationdigital twinbiomanufacturingcellular agriculturebiopharmaprocess optimizationno-code platformcomputational biologybiotech SaaSCDMOAI for sciencelab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ark Biotech Comparables

Compare Ark Biotech with similar companies based on industry and business-model similarity.

Ark Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioReact
87%
PolyModels Hub
85%
DataHow AG
84%

Ark Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 14, 2025
Series AMay 24, 2024
SeedMay 3, 2022
SeedDec 1, 2021

Key People

Founding team and executive leadership

Marília Knychala

Chief Executive Officer, Co-Founder and CEO

Founding Team

PAS Biotec

CEO

Executive Team

Zheng Huang

Chief Technology Officer

Executive Team

Ark Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 12, 2025

    Monthly visitors increased 274% MoM, from 82 to 307.

  • Aug 14, 2025

    $200K grant from BioTools Innovator and PHEMCE.

Ark Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ark Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ark Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range21
Year Founded2021
Last FundingAug 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.